1. Home
  2. RYTM vs SITM Comparison

RYTM vs SITM Comparison

Compare RYTM & SITM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • SITM
  • Stock Information
  • Founded
  • RYTM 2008
  • SITM 2003
  • Country
  • RYTM United States
  • SITM United States
  • Employees
  • RYTM N/A
  • SITM N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • SITM Semiconductors
  • Sector
  • RYTM Health Care
  • SITM Technology
  • Exchange
  • RYTM Nasdaq
  • SITM Nasdaq
  • Market Cap
  • RYTM 4.3B
  • SITM 4.7B
  • IPO Year
  • RYTM 2017
  • SITM 2019
  • Fundamental
  • Price
  • RYTM $61.99
  • SITM $228.30
  • Analyst Decision
  • RYTM Strong Buy
  • SITM Strong Buy
  • Analyst Count
  • RYTM 12
  • SITM 5
  • Target Price
  • RYTM $76.75
  • SITM $224.00
  • AVG Volume (30 Days)
  • RYTM 525.0K
  • SITM 232.5K
  • Earning Date
  • RYTM 08-05-2025
  • SITM 08-06-2025
  • Dividend Yield
  • RYTM N/A
  • SITM N/A
  • EPS Growth
  • RYTM N/A
  • SITM N/A
  • EPS
  • RYTM N/A
  • SITM N/A
  • Revenue
  • RYTM $136,863,000.00
  • SITM $229,989,000.00
  • Revenue This Year
  • RYTM $37.56
  • SITM $38.12
  • Revenue Next Year
  • RYTM $74.99
  • SITM $23.93
  • P/E Ratio
  • RYTM N/A
  • SITM N/A
  • Revenue Growth
  • RYTM 48.88
  • SITM 65.85
  • 52 Week Low
  • RYTM $39.46
  • SITM $105.40
  • 52 Week High
  • RYTM $69.89
  • SITM $268.18
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 47.67
  • SITM 72.99
  • Support Level
  • RYTM $60.70
  • SITM $204.00
  • Resistance Level
  • RYTM $62.65
  • SITM $227.71
  • Average True Range (ATR)
  • RYTM 2.39
  • SITM 8.66
  • MACD
  • RYTM -0.52
  • SITM 0.69
  • Stochastic Oscillator
  • RYTM 14.04
  • SITM 93.18

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About SITM SiTime Corporation

SiTime Corp is a provider of silicon timing systems solutions. The company designs develops and sell silicon timing systems solutions for different industries including automotive, infrastructure, aerospace-defense, consumer, internet of things, consumer and industrials. Its product offerings include Stratum 3E DCOCXOs, Programmable OCXOs, MHz Oscillators, 32.768 kHz Oscillators, Embedded Resonators, Precision MHz Super-TCXOs, and Ruggedized Oscillators. It sells its products around Taiwan, Hong Kong, the United States, and other regions and generates the majority of its revenue from Taiwan.

Share on Social Networks: